Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.3 to v3.5.4, replacing the previous version indicator. This reflects a minor update to the page's version history without altering visible content.
    Difference
    0.0%
    Check dated 2026-05-18T03:53:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the underlying clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-26T15:27:19.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Valparaiso and Araucania locations, including Temuco, Araucania, Chile (4810469) and Viña del Mar, Valparaiso, Chile (2540364). Removed Temuco, Región de la Araucanía, Chile (4810469) and Viña del Mar, Región de Valparaíso, Chile (2540364); revision updated from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-19T13:43:29.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:05:52.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous v3.4.2 revision was removed.
    Difference
    0.0%
    Check dated 2026-03-07T13:13:09.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor site version update that does not affect study content or user actions; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:07:52.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.